Search
for
Sort by
Research 121–150 of 122
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Enzalutamide/finasteride/goserelin/zoledronic-acid
- Androgenic Effects on Ventricular Repolarization
- Redefining hormone resistance in prostate cancer
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis
- Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro
- Restricted effects of androgens on glucocorticoid signaling in the mouse prefrontal cortex and midbrain
- Androgen Receptor Blockade Induces the Phagocytosis of MRSA and Pseudomonas aeruginosa by Monocyte-Derived Macrophages In Vitro
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Anogenital distance as a biomarker for incomplete masculinization : Molecular mechanisms in the perineum
- P6590Androgenic effects on ventricular repolarization: a translational study from pharmacovigilance databases to iPSC-cardiomyocytes
- Antiandrogens
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- COVID‐19, androgens, and androgenic alopecia
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence